This is a randomized controlled trial to estimate the efficacy of low dose aspirin for
preventing preeclampsia in women identified as high risk. The investigators hypothesize that
the risk of preeclampsia in women identified by a first trimester multiparameter predictive
model to be at high risk will be significantly reduced by initiating low dose aspirin early
in pregnancy.